During that time he held senior management and board positions for J&J, Novartis, and Ciba-Geigy in the U.S., Belgium, Spain, Brazil, Argentina and Switzerland. These positions include over thirty years of experience in payer markets of the U.S., Europe, and developing and emerging countries during which he held primary responsibility for monitoring global medical technology economics and health care systems and implementing international pharmaceutical policies, global pricing, reimbursement and market access decisions and global corporate participation in all local health technology assessments.
